PRODUCT

A Bio Company,
pursuing total care for human health

Product Information

Ceftazidime Inj. 1g
Active Ingredients
Ceftazidime Hydrate 1g
Indications
1. Effective species
Staphylococcus aureus susceptible staphylococcus aureus (methicillin susceptibility), methicillin susceptible epidermal aureus, cocci, streptococcus piogenes (group A-beta hemolytic), streptococcus agalactier (group B), streptococcus viridans, streptococcus (except enterococci), streptococcus pneumoniae, pseudomonas (pseudomonas aeruginosa, etc.), klebsiella (pneumococcus, etc.), proteus mirabilis, proteus vulgaris, morganella morgani, proteus providencia rettgeri, providencia, E. coli, enterobacter, citrobacter, serratia, salmonella, shigella, yersinia enterocyticica, animal pasteurella pathogen, acinetobacter, gonococcus, meningococci, influenza (including ampicillin-resistant bacteria), parainfluenza bacteria (including ampicillin-resistant bacteria), peptococci, propionibacterium, clostridium perfringens, fusobacterium, bacteroids (except B. fragilis)
2. Indications
1) Sepsis, meningitis
2) Pulmonary infections in patients with pneumonia, pleurisy, empyema, lung abscess, bronchiectasis (when infected), bronchitis, cystic fibrosis
3) Otitis media, malignant otitis media, mastoiditis, sinusitis
4) Pyelonephritis, prostatitis, cystitis, bacterial urethritis
5) Secondary infection, mastitis, skin ulcer alone, abscess, burn and trauma
6) Cholangitis, cholecystitis, empyema of gallbladder, peritoneal abscess, peritonitis, diverticulitis, small intestinal colitis, pelvic infection
7) Osteomyelitis, osteoarthritis, septic arthritis, infectious bursitis
8) Severe infections in immunocompromised patients, severe infections such as burn infections, infections caused by blood and peritoneal dialysis, and infections associated with persistent outpatient peritoneal dialysis (CAPD) patients

1. Adults: Ceftazidime once with 0.5 to 2 g (potency) intravenously or intramuscularly 2-3 times a day. In most infectious diseases, 1 g (potency) is injected intravenously or intramuscularly every 8 hours or 2 g (potency) every 12 hours